Drug profile · INN
betrixaban
DEXXIENCE
betrixaban (DEXXIENCE) is a coagulation factor x inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — betrixaban
- US status
- approved
- Class
- Blood and blood forming organs (B01)
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
betrixaban (DEXXIENCE) is a coagulation factor x inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Coagulation factor X inhibitor
Primary target: Coagulation factor X
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | refused | — |
Related & competitor drugs
Frequently asked questions
What is betrixaban?
betrixaban (DEXXIENCE) is a coagulation factor x inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for betrixaban?
DEXXIENCE is a marketed brand name for betrixaban. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of betrixaban?
betrixaban has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.